NVIC Articles

Federal Vaccine Advisory Committees

Latest articles

Browse Articles

Placeholder image
Article

On May 23, 2025, NVIC submitted a written public comment to the US Food and Drug Administration’s Vaccines & Related Biological Products Advisory Committee (VRBPAC) signed by two former consumer...

Placeholder image
Article

On May 23, 2025, NVIC submitted a written public comment to the US Food and Drug Administration’s Vaccines & Related Biological Products Advisory Committee (VRBPAC) signed by two former consumer...

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously on June 5th to recommend that the FDA update the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain to replace the XBB1.5 strain.
Article

The FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend updating the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain, citing the current vaccine's ineffectiveness against emerging variants. Despite the absence of safety data, the committee emphasized the importance of vaccine effectiveness, while noting the potential for rapid variant evolution which might impact vaccine efficacy. Manufacturers like Moderna, Pfizer, and Novavax presented promising data for their new vaccine candidates, with an emphasis on preparedness to meet the FDA's upcoming strain decision.

Impending Changes to Vaccine Injury Compensation
Article

Stay informed on impending changes to vaccine injury compensation with Theresa Wrangham's latest article. Learn about the expected release of a pivotal report by the National Academy of Medicine and its potential impact on the Vaccine Injury Table, alongside updates on membership vacancies and compensation trends.

RSV Vaccine Recommended for Pregnant Women
Article

Learn about the ACIP recommendation for Pfizer's Abrysvo RSV vaccine in pregnant women, the controversy surrounding its testing, and the potential impact on preterm births – all in our eye-opening article on RSV vaccination strategies.

CDC's Expert Committee Votes to Treat Drug Like Vaccine
Article

Learn about CDC's treatment of the RSV drug nirsevimab as a vaccine and potential impacts to vaccine mandates, tracking and injury compensation.

NVIC referenced public comment regarding FDA advisory committee consideration of future COVID-19 regimens.
Article

Read NVIC's referenced public comment on FDA future COVID-19 regimens and call for withdrawal of mRNA COVID-19 vaccines.

Details on Covid-19 and vaccine injury compensation.
Article

Learn about the implications of the addition of COVID-19 vaccines to the federal vaccine schedules and implications for vaccine injury compensation.

The National Vaccine Information Center opposes addition of COVID-19 to the CDC’s recommended childhood vaccine schedule.
Article

Learn about ACIP's October 2022 vote to add COVID-19 to the childhood vaccination schedule.

Summary of statement on needed reforms in federal Vaccine Injury Compensation Program.
Article

On Nov. 14, 1986, President Ronald Reagan signed the National Childhood Vaccine Injury Act of 1986 into law, instituting first-time vaccine safety reforms in the U.S. vaccination system and creating...

Select disease / vaccine